Clinical trial · Observational
Long-term Evaluation of Fertility Preservation Options in Women in Cancer Remission or Haematological Pathology
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Cancer treatments, despite their increasing effectiveness, carry a significant risk of gamete toxicity. Women of reproductive age are commonly offered fertility preservation (FP) before starting their treatment. However, few studies have analyzed the long-term reproductive outcomes of these interventions, nor how patients ultimately use or do not use the FP options once in remission. This project aims to better understand the effectiveness, utilization, and psychological impacts of these strategies. This work is part of an effort to understand and evaluate fertility preservation practices implemented for women of reproductive age undergoing cancer treatment at the Amiens-Picardie University Hospital (CHU). Its objective is to document patient pathways, clinical decisions, techniques employed, and reproductive outcomes observed after remission, in order to identify potential areas for improvement in the support and follow-up of these patients, thereby enhancing the overall quality and coordination of care. This work is conducted alongside the development of a fertility observatory at the Department of Medicine and Reproductive Biology, CHU Amiens-Picardie.
Conditions
Conditions (13)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Assisted Reproductive Technology | — | UNRESOLVED | — |
| Cancer Remission | — | UNRESOLVED | — |
| Female Cancer Survivors | — | UNRESOLVED | — |
| Fertility Counseling | — | UNRESOLVED | — |
| Fertility Observatory | — | UNRESOLVED | — |
| Fertility Preservation | — | UNRESOLVED | — |
| Fertility Preservation Techniques | — | UNRESOLVED | — |
| Live Birth Rate | — | UNRESOLVED | — |
| Oncology | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Occurrence of an identifiable reproductive outcome
- timeFrame
- 1 year
- description
- Identifiable reproductive outcome are Spontaneous pregnancy, Use of preserved gametes or ovarian tissue (whether or not resulting in pregnancy), Use of donor oocytes, Discontinuation of the parenthood project
Secondary outcomes (11)
- measure
- Type of fertility preservation method performed
- timeFrame
- 1 year
- measure
- Time interval (in months) between diagnosis and fertility preservation
- timeFrame
- 1 year
- measure
- Correlation between Age and occurance of an identifiable reproductive outcome
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 47 Years
Show eligibility criteria text
Inclusion Criteria: * Women * Aged between 18 and 47 years * Diagnosed with cancer or hematological disorders requiring potentially gonadotoxic treatment * Having undergone a medical fertility preservation consultation * Followed at Amiens Picardie University Hospital (CHU Amiens Picardie) in the department of Reproductive Medicine * Currently in remission * Having expressed non-opposition to participation in the study Exclusion Criteria: * Absence of remission * Patients deprived of liberty by administrative or judicial decision, or placed under legal protection (guardianship or curators) * Decline to participate in the study
References
Publications (0)
Data not yet available